DXMS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DXMS, covering 2023-03-07 to 2023-03-07. Get the full timeline:
Most recent: Clinical Trial Update: APG-2575 Monotherapy or in Combination With Lenalidomide/DXMS in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]